Patents-Review.com
ClassID:

115486 ⎘

C12Y204/0203 - CPC Classification

Classification description:

Glycosyltransferases (2.4); Pentosyltransferases (2.4.2) NAD+ ADP-ribosyltransferase (2.4.2.30), i.e. tankyrase or poly(ADP-ribose) polymerase

Recent Application in this class:
#1
20260027222
2026-01-29

PEPTIDE LINKERS FOR CONSTRUCTION AND REDUCING AGGREGATION OF FUSION POLYPEPTIDES COMPRISING SUCH

 #2
20250002962
2025-01-02

RNAYLATION

 #3
20240252689
2024-08-01

POLY-ADP RIBOSE (PAR) TRACKER OPTIMIZED SPLIT-PROTEIN REASSEMBLY PAR DETECTION REAGENTS

 #4
20240241113
2024-07-18

Method for detecting binding to an ADP-ribosyl group or a polymer thereof and a kit for performing said method

 #5
20220062286
2022-03-03

USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER

 #6
20210299137
2021-09-30

COMPOUNDS, COMPOSITIONS, AND METHODS FOR TREATMENT OF DISEASES INVOLVING ACIDIC OR HYPOXIC DISEASED TISSUES

 #7
20200407700
2020-12-31

COMPOSITIONS OF PARP14 MODULATORS AND/OR MUTANTS AND THERAPEUTIC USE THEREOF

 #8
20200368319
2020-11-26

Vault complexes for cytokine delivery

 #9
20200325482
2020-10-15

PARP9 and PARP14 as key regulators of macrophage activation

 #10
20200237762
2020-07-30

USE OF RNAI INHIBITING PARP ACTIVITY FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF CANCER

 #11
20200232042
2020-07-23

Methods for determining response to PARP inhibitors

 #12
20200123192
2020-04-23

Compounds and methods used in assessing mono-PARP activity

 #13
20200024581
2020-01-23

Methods and compositions for vault nanoparticle immobilization of therapeutic molecules and for vault targeting

 #14
20190282639
2019-09-19

Viral vectors for treating Parkinson's disease

 #15
20190209580
2019-07-11

Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues

 #16
20190091220
2019-03-28

TARGETING PARP1 FOR TREATMENT OF TSC AND CANCERS

 #17
20180223288
2018-08-09

COMPOSITIONS AND METHODS FOR THE MODULATION OF DNA DAMAGE RESPONSES USING BAL1 AND BBAP

 #18
20180110777
2018-04-26

METHOD FOR REGULATION OF TELOMERE LENGTH

 #19
20180064746
2018-03-08

Assay for telomere length regulators

 #20
20180057888
2018-03-01

KUB5/HERA AS A DETERMINANT OF SENSITIVITY TO DNA DAMAGE

 #21
20180024129
2018-01-25

Lateral flow device and method of use

 #22
20180000822
2018-01-04

Use of RNAI Inhibiting PARP Activity for the Manufacture of a Medicament for the Treatment of Cancer

 #23
20170146517
2017-05-25

COMPOUNDS AND METHODS USED IN ASSESSING MONO-PARP ACTIVITY

 #24
20170143797
2017-05-25

Vault complexes for cytokine delivery

 #25
20170049771
2017-02-23

Targeting PARP1 for treatment of TSC and cancers

 #26
20160367653
2016-12-22

Vault immunotherapy

 #27
20160289685
2016-10-06

Method of inhibiting macrophage activation using an inhibitor of PARP9

 #28
20160287622
2016-10-06

COMPOSITIONS AND METHODS FOR TREATING IMMUNE AND VIRAL DISORDERS AND MODULATING PROTEIN-RNA INTERACTION

 #29
20160251669
2016-09-01

POLLEN PREFERRED PROMOTERS AND METHODS OF USE

 #30
20160068576
2016-03-10

Vault complexes

 #31
20160010067
2016-01-14

NOVEL POLY(ADP-RIBOSE) POLYMERASE GENES

 #32
20150020221
2015-01-15

Compositions and methods for the modulation of DNA damage responses using BAL1 and BBAP

 #33
20140341876
2014-11-20

METHOD FOR THE TREATMENT OF PULMONARY DISEASE AND METHOD OF PRODUCING PROTEINS OF USE THEREIN

 #34
20130180006
2013-07-11

Pollen preferred promoters and methods of use

 #35
20130065761
2013-03-14

Methods for Increasing the Resistance of Plants to Hypoxic Conditions

 #36
20130039894
2013-02-14

Polypeptides and use thereof for treatment of traumatic or degenerative neuronal injury

 #37
20120213809
2012-08-23

Vault complexes for cytokine delivery

 #38
20120164123
2012-06-28

Method for the treatment of pulmonary disease and method of producing proteins of use therein

 #39
20110201112
2011-08-18

Vault complexes for facilitating biomolecule delivery

 #40
20110107444
2011-05-05

Poly(ADP-ribose) polymerase genes

 #41
20100330583
2010-12-30

Compositions and methods for identification of PARP function, inhibitors, and activators

 #42
20090064371
2009-03-05

Methods for increasing the resistance of plants to hypoxic conditions

 #43
20070179160
2007-08-02

Use of RNAI inhibiting PARP activity for the manufacture of a medicament for the treatment of cancer

 #44
20070072841
2007-03-29

Therapeutic compounds

 #45
20050143370
2005-06-30

Therapeutic compounds